KDx Diagnostics Inc. and UroGPO Announce a Partnership to Offer the URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States ...Middle East

SAN JOSE, Calif. and CLEVELAND, May 27, 2022 /PRNewswire/ -- KDx Diagnostics and UroGPO announced today the partnership to provide the URO17® test (Research Use Only in the US) for the detection of bladder cancer. URO17® is a non-invasive urine test with high sensitivity and negative...

Hence then, the article about kdx diagnostics inc and urogpo announce a partnership to offer the uro17 non invasive urine test for bladder cancer in the united states was published today ( Saturday 28/05/2022 - 01:52 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( KDx Diagnostics Inc. and UroGPO Announce a Partnership to Offer the URO17® NON-INVASIVE Urine Test for Bladder Cancer in the United States )

Also on site :

• Suspect in Mississippi synagogue fire laughed as he confessed to his dad, authorities say
• Fire crews and Hazmat teams responded to fire involving lithium ion batteries at Higuera Street facility
• No injuries reported after partial building collapse in the Bronx, officials say